Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 21
Phase 43

Trial Status

Terminated1
Other3

Role Distribution

Principal Investigator3
Other Roles1
PI Rate75%

Activity Timeline

Clinical Trials (4)

NCT00499551Phase 1/2Withdrawn
A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis
Uveitis
StudydirectorStart date: 2007-09-01
NCT00563121Phase 4Withdrawn
VEGF Levels in Aqueous, Vitreous and Subretinal Fluid in ROP Stage IV and V
Retinopathy of Prematurity
PrincipalinvestigatorStart date: 2007-03-01
NCT00496405Phase 4Withdrawn
Unilateral Bevacizumab for Bilateral Diabetic Macular Edema
Diabetic Macular EdemaDiabetic Retinopathy
Principalinvestigator
NCT00500396Phase 4Terminated
Vascular Endothelial Growth Factor in Stage V ROP
Retinopathy of Prematurity
Principalinvestigator

Research Network

Collaboration Network

13 collaborators·13 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Asociación para Evitar la Ceguera en Mexico

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Hugo Quiroz-Mercado, MD

Asociación para Evitar la Ceguera en México

Moderately Similar
8 trials

Shared therapeutic areas:

Diabetic Macular EdemaDiabetic RetinopathyRetinopathy of Prematurity

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 1 trial
Similarity Score34%

Hugo Quiroz-Mercado, MD

Asociación para Evitar la Ceguera en Mexico

Related
2 trials

Shared therapeutic areas:

Retinopathy of PrematurityUveitis

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 2 trials
Similarity Score28%

Lourdes Arellanes, MD

Asociación para Evitar la Ceguera en Mexico

Related
1 trials

Shared therapeutic areas:

Uveitis

Worked with same sponsors:

Asociación para Evitar la Ceguera en México
Collaborated on 1 trial
Similarity Score14%

Seetha Shankaran, MD

Wayne State University

Related
49 trials

Shared therapeutic areas:

Retinopathy of Prematurity
Similarity Score8%

Dale L. Phelps, MD

University of Rochester

Related
10 trials

Shared therapeutic areas:

Retinopathy of Prematurity
Similarity Score8%

Abhik Das, PhD

RTI International

Related
31 trials

Shared therapeutic areas:

Retinopathy of Prematurity
Similarity Score8%

Michele C. Walsh, MD MS

Case Western Reserve University, Rainbow Babies and Children's Hospital

Related
11 trials

Shared therapeutic areas:

Retinopathy of Prematurity
Similarity Score8%

Carl T D'Angio, MD

University of Rochester

Related
10 trials

Shared therapeutic areas:

Retinopathy of Prematurity
Similarity Score8%

Waldemar A Carlo, MD

University of Alabama at Birmingham

Related
29 trials

Shared therapeutic areas:

Retinopathy of Prematurity
Similarity Score8%

Neil N. Finer, MD

University of California, San Diego

Related
11 trials

Shared therapeutic areas:

Retinopathy of Prematurity
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT00499551Phase 1/2StudyDirector

A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis

Uveitis
Withdrawn
NCT00563121Phase 4PrincipalInvestigator

VEGF Levels in Aqueous, Vitreous and Subretinal Fluid in ROP Stage IV and V

Retinopathy of Prematurity
Withdrawn
NCT00496405Phase 4PrincipalInvestigator

Unilateral Bevacizumab for Bilateral Diabetic Macular Edema

Diabetic Macular EdemaDiabetic Retinopathy
Withdrawn
NCT00500396Phase 4PrincipalInvestigator

Vascular Endothelial Growth Factor in Stage V ROP

Retinopathy of Prematurity
Terminated

All 4 trials loaded